combretastatin has been researched along with Fibrosarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, Q; Guo, D; Jiang, X; Li, Z; Qi, H; Wu, Y; Xu, J; Yang, F; Zhang, W; Zuo, D | 1 |
1 other study(ies) available for combretastatin and Fibrosarcoma
| Article | Year |
|---|---|
3-(3-Hydroxy-4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazole (G-1103), a novel combretastatin A-4 analog, induces G2/M arrest and apoptosis by disrupting tubulin polymerization in human cervical HeLa cells and fibrosarcoma HT-1080 cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Bibenzyls; Caspase 8; Caspase 9; cdc25 Phosphatases; Cell Line, Tumor; Cyclin B1; Down-Regulation; Female; Fibrosarcoma; G2 Phase Cell Cycle Checkpoints; Guaiacol; HeLa Cells; Humans; M Phase Cell Cycle Checkpoints; Microtubules; Organoselenium Compounds; Proto-Oncogene Proteins c-bcl-2; Up-Regulation; Uterine Cervical Neoplasms | 2015 |